Nitric oxide-induced adenosine inhibition of hippocampal synaptic transmission depends on adenosine kinase inhibition and is cyclic GMP independent

被引:10
作者
Arrigoni, Elda [1 ]
Rosenberg, Paul A.
机构
[1] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[2] Childrens Hosp, Dept Neurol, Boston, MA 02215 USA
[3] Childrens Hosp, Neurobiol Program, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA
关键词
evoked field potentials; in vitro; rats; sleep; zaprinast;
D O I
10.1111/j.1460-9568.2006.05124.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Adenosine is an important inhibitory neuromodulator that regulates neuronal excitability. Several studies have shown that nitric oxide induces release of adenosine. Here we investigated the mechanism of this release. We studied the effects of nitric oxide on evoked field excitatory postsynaptic potentials (fEPSPs) recorded in the CA1 area of rat hippocampal slices. The nitric oxide donor 1,1-diethyl-2-hydroxy-2-nitroso-hydrazine sodium (DEA/NO; 100 mu M) depressed the fEPSP by 77.6 +/- 4.1%. This effect was abolished by the adenosine A1 antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 400 nM), indicating that the nitric oxide effect was mediated by adenosine accumulation. The DEA/NO effect was unaltered by the 5'-ectonucleotidase inhibitor alpha,beta-methylene-adenosine 5'-diphosphate (AMP-CP; 100 mu M), indicating that extracellular adenosine did not derive from ATP or cAMP release. The guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazole[4,3-a]quinoxaline-1-one (ODQ; 5 mu M) did not affect nitric oxide depression of the fEPSPs, indicating that nitric oxide-mediated adenosine release was not mediated through a cGMP signaling cascade. This conclusion was confirmed by the observation that 8-(4-chlorophenylthio)-guanosine-3',5'-cyclic monophosphate (8-pCPT-cGMP; 1 mM) reversibly depressed the fEPSP by 24.9 +/- 4.5%, but this effect was not blocked by adenosine antagonists. Adenosine kinase inhibitor 5-iodotubercidin (ITU; 7 mu M) occluded the nitric oxide effects by 74%, suggesting that inhibition of adenosine kinase activity contributes to adenosine release. In conclusion, exogenous nitric oxide evokes adenosine release by a cGMP-independent pathway. Intracellular cGMP elevation partially inhibits the fEPSP but not through adenosine release. Although a direct block of adenosine kinase by nitric oxide can not be excluded, the depression of adenosine kinase activity may be due to inhibition by its own substrate adenosine.
引用
收藏
页码:2471 / 2480
页数:10
相关论文
共 84 条
[71]   ADENOSINE INHIBITION OF MESOPONTINE CHOLINERGIC NEURONS - IMPLICATIONS FOR EEG AROUSAL [J].
RAINNIE, DG ;
GRUNZE, HCR ;
MCCARLEY, RW ;
GREENE, RW .
SCIENCE, 1994, 263 (5147) :689-692
[72]   Nitric oxide-stimulated increase in extracellular adenosine accumulation in rat forebrain neurons in culture is associated with ATP hydrolysis and inhibition of adenosine kinase activity [J].
Rosenberg, PA ;
Li, Y ;
Le, MN ;
Zhang, YM .
JOURNAL OF NEUROSCIENCE, 2000, 20 (16) :6294-6301
[73]   Molecular characterization of recombinant mouse adenosine kinase and evaluation as a target for protein phosphorylation [J].
Sahin, B ;
Kansy, JW ;
Nairn, AC ;
Spychala, J ;
Ealick, SE ;
Fienberg, AA ;
Greene, RW ;
Bibb, JA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (17) :3547-3555
[74]   Involvement of nitric oxide in adenosine release in the developing and adult mouse hippocampus [J].
Saransaari, P ;
Oja, SS .
NEUROCHEMICAL RESEARCH, 2004, 29 (01) :219-225
[75]   Release of nitric oxide from donors with known half-life: A mathematical model for calculating nitric oxide concentrations in aerobic solutions [J].
Schmidt, K ;
Desch, W ;
Klatt, P ;
Kukovetz, WR ;
Mayer, B .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) :457-462
[76]   Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation [J].
Sinclair, CJD ;
Shepel, PN ;
Geiger, JD ;
Parkinson, FE .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (05) :477-483
[77]   Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects [J].
Smolenski, A ;
Burkhardt, AM ;
Eigenthaler, M ;
Butt, E ;
Gambaryan, S ;
Lohmann, SM ;
Walter, U .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) :134-139
[78]   Neuroprotective effects of adenosine in cerebral ischemia, window of opportunity [J].
Sweeney, MI .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (02) :207-217
[79]   Adenosine transporters [J].
Thorn, JA ;
Jarvis, SM .
GENERAL PHARMACOLOGY, 1996, 27 (04) :613-620
[80]  
TRUSSELL LO, 1987, J NEUROSCI, V7, P3306